Page last updated: 2024-10-30

lorazepam and Emesis

lorazepam has been researched along with Emesis in 93 studies

Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Research Excerpts

ExcerptRelevanceReference
"To describe the use of ketamine in an adult patient in aborting a cyclic vomiting syndrome (CVS) episode."9.22Ketamine in Refractory Cyclic Vomiting Syndrome: A Case Report and Review of Literature. ( Cheung, F; Doherty, SM; Tatara, AW, 2022)
"The objective of this double blind parallel-group multicentre study was to compare the efficacy and safety of the combination ondansetron + methylprednisolone + lorazepam (O + M + L) in the prevention of emesis induced by chemotherapy with cyclophosphamide or adriamycin ."9.09[Improvement in the control of chemotherapy induced emesis with ondansetron, methylprednisolone and lorazepam combination in patients treated by a moderate emetic treatment and uncontrolled by a previous antiemetic combination]. ( Bonneterre, J; Harousseau, JL; Hedouin, M; Ouvry, J; Zittoun, R, 2000)
" Patients were randomised into one of two groups, receiving either granisetron, a specific 5-HT3 antagonist or a combination of metoclopramide, dexamethasone phosphate and lorazepam to assess the comparative efficacy of the two regimens in the control of irradiation-induced nausea and vomiting."9.08Granisetron in the prevention of irradiation-induced emesis. ( Collis, C; Cunningham, J; Cunningham, S; Gandhi, L; Hamon, MD; Prentice, HG, 1995)
"This study was carried out to assess the efficacy of oral lorazepam on postoperative nausea and vomiting in patients undergoing thyroid surgery."9.08[Prevention of postoperative nausea and vomiting by lorazepam]. ( Benaguida, M; Bouaguad, A; el Mouknia, M; Idali, B; Laraki, M, 1996)
"Vomiting was prevented in two thirds of patients treated with MDL plus ondansetron, a result similar to that observed in earlier trials of MDL alone."9.07The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatin. ( Baltzer, L; Kris, MG; Pisters, KM; Rigas, JR; Tyson, LB, 1994)
" Because lorazepam used as an antiemetic in children during chemotherapy decreased the incidence of nausea and vomiting, we compared the antiemetic effects of lorazepam and droperidol in a randomized, double-blind, placebo-controlled study of 129 healthy children undergoing surgical correction of strabismus."9.07The antiemetic effect of lorazepam after outpatient strabismus surgery in children. ( Berry, JM; Hanis, C; Howard, G; Khalil, SN; Lawson, K; Mazow, ML; Stanley, TH, 1992)
"Ondansetron was very effective in the prevention of nausea and vomiting during the acute phase after cisplatin administration."9.07A randomized double-blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and lorazepam in the prevention of emesis due to cisplatin-based chemotherapy. ( Ahn, MJ; Choi, SS; Kim, SH; Lee, JS; Lee, KH; Suh, C, 1994)
"The efficacy and tolerability of tropisetron in preventing cisplatin-induced nausea and vomiting was studied in 2 open trials and compared with the efficacy and tolerability of metoclopramide plus lorazepam in a randomised crossover trial."9.07Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients. ( Antonacci, RA; Berruti, A; Dogliotti, L; Faggiuolo, R; Ortega, C; Pazè, E, 1992)
"To determine the severity of emesis caused by ultra-high-dose cisplatin-carboplatin chemotherapy and to compare the antiemetic efficacy of an ondansetron regimen and a metoclopramide regimen."9.07Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy. ( Fanning, J; Hilgers, RD, 1994)
" Lorazepam and dexamethasone are increasingly being used to alleviate chemotherapy induced emesis."9.06The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial. ( Blackledge, GR; Burman, C; Cullen, MH; Kelly, K; O'Brien, ME; Palmer, K; Sharpe, J; Stuart, NS; Woodroffe, C, 1989)
"Sixty-four patients treated with cisplatin-containing regimens were entered into a randomized, double-blinded study examining the antiemetic efficacy of metoclopramide with and without lorazepam for control of cisplatin-induced emesis."9.06Metoclopramide versus metoclopramide and lorazepam. Superiority of combined therapy in the control of cisplatin-induced emesis. ( Al-Sarraf, M; Cummings, G; Gordon, CJ; Pazdur, R; Ziccarelli, A, 1989)
"To evaluate the efficacy and adverse events associated with the use of haloperidol for the treatment of nausea and vomiting in palliative care patients."8.91Haloperidol for the treatment of nausea and vomiting in palliative care patients. ( Dorman, S; Murray-Brown, F, 2015)
" Delayed emesis following Cycle 1 of carboplatin was observed in 30% of patients."7.83Delayed nausea and vomiting from carboplatin doublet chemotherapy. ( Baggstrom, MQ; Chitneni, P; Gao, F; Govindan, R; Mann, J; Morgensztern, D; Waqar, MA; Waqar, SN; Williams, K, 2016)
" From October 1995 to January 1997, prevention of emesis with granisetron 3 mg/12 h i."7.70The antiemetic efficacy of granisetron plus dexamethasone, haloperidol and loracepam in breast cancer patients treated with high-dose chemotherapy with peripheral blood stem-cell support. ( Aznar, E; Climent, MA; Guillem, V; Olmos, T; Palau, J; Ruiz, A; Soriano, V, 1998)
"Vomiting was suppressed in cats pretreated with 8-OH-DPAT and then challenged with an emetic stimulus; motion, xylazine or cisplatin."7.678-OH-DPAT suppresses vomiting in the cat elicited by motion, cisplatin or xylazine. ( Crampton, GH; Lucot, JB, 1989)
"An oral combination of cinnarizine and lorazepam was studied for the prophylaxis of nausea and vomiting induced by strongly emetogenic cancer chemotherapy."7.67Antiemetic prophylaxis of cancer chemotherapy-induced nausea and vomiting with cinnarizine and lorazepam. ( Senn, HJ; Wilder-Smith, CH, 1989)
"Nausea and vomiting are extremely common and most distressing side effects of high-dose cisplatin therapy."6.68Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial. ( Ata, E; Butt, A; Khan, MA; Khan, WA; Malik, IA; Qazilbash, M, 1995)
"Severe nausea was significantly less frequent with cinnarizine and 59% of the chemotherapy days were without nausea, compared to 46% of the days without cinnarizine (p less than 0."6.67Cinnarizine for prevention of nausea and vomiting during platin chemotherapy. ( Osterwalder, B; Schimke, J; Senn, HJ; Wilder-Smith, CH, 1991)
"Vomiting was observed in 47/71 patients (66%) and 79/164 cycles (48%)."5.51Impact of adjuvant lorazepam with granisetron on chemotherapy-induced nausea and vomiting in pediatric patients with acute lymphoblastic leukemia. ( Goldman, RD; Hasegawa, D; Kishimoto, K; Kosaka, Y; Ono, A, 2019)
"Despite treatment, emesis remains a major problem with cisplatin chemotherapy."5.28[Improved control of cisplatin-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam]. ( Hsu, KP; Li, YT; Mau, YK; Tsui, MS; Tu, FC, 1991)
"To describe the use of ketamine in an adult patient in aborting a cyclic vomiting syndrome (CVS) episode."5.22Ketamine in Refractory Cyclic Vomiting Syndrome: A Case Report and Review of Literature. ( Cheung, F; Doherty, SM; Tatara, AW, 2022)
"The topical gel known as "ABH gel," comprising lorazepam (Ativan(®)), diphenhydramine (Benadryl(®)), and haloperidol (Haldol(®)), is frequently used to treat nausea because of its perceived efficacy, relatively low cost, and ease of use in the home setting."5.19A randomized trial of the effectiveness of topical "ABH Gel" (Ativan(®), Benadryl(®), Haldol(®)) vs. placebo in cancer patients with nausea. ( Coyne, PJ; Dodson, PW; Fletcher, DS; Parker, GG; Smith, TJ; Wan, W, 2014)
"The objective of this double blind parallel-group multicentre study was to compare the efficacy and safety of the combination ondansetron + methylprednisolone + lorazepam (O + M + L) in the prevention of emesis induced by chemotherapy with cyclophosphamide or adriamycin ."5.09[Improvement in the control of chemotherapy induced emesis with ondansetron, methylprednisolone and lorazepam combination in patients treated by a moderate emetic treatment and uncontrolled by a previous antiemetic combination]. ( Bonneterre, J; Harousseau, JL; Hedouin, M; Ouvry, J; Zittoun, R, 2000)
"This study was carried out to assess the efficacy of oral lorazepam on postoperative nausea and vomiting in patients undergoing thyroid surgery."5.08[Prevention of postoperative nausea and vomiting by lorazepam]. ( Benaguida, M; Bouaguad, A; el Mouknia, M; Idali, B; Laraki, M, 1996)
"Both metoclopramide and prochlorperazine in combination with lorazepam and diphenhydramine offer good control of nausea and vomiting although the sedation and low risk for cardiac toxicity limit the regimen to an inpatient setting with close monitoring."5.08Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation. ( Gilbert, CJ; Ohly, KV; Peters, WP; Rosner, G, 1995)
" Patients were randomised into one of two groups, receiving either granisetron, a specific 5-HT3 antagonist or a combination of metoclopramide, dexamethasone phosphate and lorazepam to assess the comparative efficacy of the two regimens in the control of irradiation-induced nausea and vomiting."5.08Granisetron in the prevention of irradiation-induced emesis. ( Collis, C; Cunningham, J; Cunningham, S; Gandhi, L; Hamon, MD; Prentice, HG, 1995)
"To determine the severity of emesis caused by ultra-high-dose cisplatin-carboplatin chemotherapy and to compare the antiemetic efficacy of an ondansetron regimen and a metoclopramide regimen."5.07Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy. ( Fanning, J; Hilgers, RD, 1994)
"The efficacy and tolerability of tropisetron in preventing cisplatin-induced nausea and vomiting was studied in 2 open trials and compared with the efficacy and tolerability of metoclopramide plus lorazepam in a randomised crossover trial."5.07Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients. ( Antonacci, RA; Berruti, A; Dogliotti, L; Faggiuolo, R; Ortega, C; Pazè, E, 1992)
"Ondansetron was very effective in the prevention of nausea and vomiting during the acute phase after cisplatin administration."5.07A randomized double-blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and lorazepam in the prevention of emesis due to cisplatin-based chemotherapy. ( Ahn, MJ; Choi, SS; Kim, SH; Lee, JS; Lee, KH; Suh, C, 1994)
" Because lorazepam used as an antiemetic in children during chemotherapy decreased the incidence of nausea and vomiting, we compared the antiemetic effects of lorazepam and droperidol in a randomized, double-blind, placebo-controlled study of 129 healthy children undergoing surgical correction of strabismus."5.07The antiemetic effect of lorazepam after outpatient strabismus surgery in children. ( Berry, JM; Hanis, C; Howard, G; Khalil, SN; Lawson, K; Mazow, ML; Stanley, TH, 1992)
"Vomiting was prevented in two thirds of patients treated with MDL plus ondansetron, a result similar to that observed in earlier trials of MDL alone."5.07The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatin. ( Baltzer, L; Kris, MG; Pisters, KM; Rigas, JR; Tyson, LB, 1994)
"This pilot randomized study compared MDL 72,222, a highly selective 5-HT3 receptor antagonist, with a high-dose metoclopramide regimen (HDM) for chemotherapy-induced nausea and vomiting."5.07Randomized comparison of the antiemetic efficacy of a serotonin type 3 receptor antagonist (MDL 72,222) with a high-dose metoclopramide regimen. ( Barrett, RJ; Hahne, WF; Heck, K; Homesley, HD; Lentz, SS; Lovelace, JV; McLees, B; Woodlief, L, 1993)
" Lorazepam and dexamethasone are increasingly being used to alleviate chemotherapy induced emesis."5.06The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial. ( Blackledge, GR; Burman, C; Cullen, MH; Kelly, K; O'Brien, ME; Palmer, K; Sharpe, J; Stuart, NS; Woodroffe, C, 1989)
"Sixty-four patients treated with cisplatin-containing regimens were entered into a randomized, double-blinded study examining the antiemetic efficacy of metoclopramide with and without lorazepam for control of cisplatin-induced emesis."5.06Metoclopramide versus metoclopramide and lorazepam. Superiority of combined therapy in the control of cisplatin-induced emesis. ( Al-Sarraf, M; Cummings, G; Gordon, CJ; Pazdur, R; Ziccarelli, A, 1989)
"Combinations of metoclopramide and dexamethasone given intravenously control vomiting caused by high doses of cisplatin."5.06Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial. ( Clark, RA; Gralla, RJ; Groshen, S; Kris, MG; Tyson, LB, 1987)
"The present trial was designed to compare the effect of metoclopramide(MCP) + dexamethasone(DM) (Method A) with that of MCP + DM + lorazepam(Lor) (Method B) in the treatment of CDDP (cis-diamminedichloroplatinum)-induced nausea and vomiting in a randomized fashion."5.06[Anti-emetic treatment with metoclopramide and other drugs during CDDP therapy]. ( Arai, R; Furuse, K; Hayashi, S; Kawahara, M; Kiyota, T; Kodama, N; Tsuruta, S, 1987)
"Lorazepam was compared to placebo to assess its control of nausea and vomiting in patients receiving cytotoxic chemotherapy and prochlorperazine."5.05Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine. ( Bingham, J; Bishop, JF; Cooper, IA; Hillcoat, BL; Long, M; Matthews, JP; Olver, IN; Wolf, MM, 1984)
"To evaluate the efficacy and adverse events associated with the use of haloperidol for the treatment of nausea and vomiting in palliative care patients."4.91Haloperidol for the treatment of nausea and vomiting in palliative care patients. ( Dorman, S; Murray-Brown, F, 2015)
" Delayed emesis following Cycle 1 of carboplatin was observed in 30% of patients."3.83Delayed nausea and vomiting from carboplatin doublet chemotherapy. ( Baggstrom, MQ; Chitneni, P; Gao, F; Govindan, R; Mann, J; Morgensztern, D; Waqar, MA; Waqar, SN; Williams, K, 2016)
" Indications for droperidol included agitation, 68 (86%); nausea/vomiting, 7 (9%); headache, 2 (3%); and other pain, 2 (3%)."3.76Droperidol use in pediatric emergency department patients. ( Sacchetti, A; Szwak, K, 2010)
" From October 1995 to January 1997, prevention of emesis with granisetron 3 mg/12 h i."3.70The antiemetic efficacy of granisetron plus dexamethasone, haloperidol and loracepam in breast cancer patients treated with high-dose chemotherapy with peripheral blood stem-cell support. ( Aznar, E; Climent, MA; Guillem, V; Olmos, T; Palau, J; Ruiz, A; Soriano, V, 1998)
"Lorazepam, dexamethasone and high-dose metoclopramide were given to 54 patients to prevent emesis induced by cisplatin (50-120 mg/m2) on day 1, while prochlorperazine and dexamethasone were administered on days 2 and 3 for control of delayed emesis."3.68Acute and delayed emesis after cisplatin-based regimen: description and prevention. ( Beaulieu, R; Courchesne, Y; Latreille, J; Letendre, F; Lorange, A; Louvet, C; Monte, M; Neemeh, JA; Pretty, HM, 1991)
"Vomiting was suppressed in cats pretreated with 8-OH-DPAT and then challenged with an emetic stimulus; motion, xylazine or cisplatin."3.678-OH-DPAT suppresses vomiting in the cat elicited by motion, cisplatin or xylazine. ( Crampton, GH; Lucot, JB, 1989)
"An oral combination of cinnarizine and lorazepam was studied for the prophylaxis of nausea and vomiting induced by strongly emetogenic cancer chemotherapy."3.67Antiemetic prophylaxis of cancer chemotherapy-induced nausea and vomiting with cinnarizine and lorazepam. ( Senn, HJ; Wilder-Smith, CH, 1989)
"5 mg intravenous haloperidol in an effort to improve patient tolerance of cytotoxic chemotherapy and decrease nausea and vomiting."3.66Lorazepam as an adjunct to antiemetic therapy with haloperidol in patients receiving cytotoxic chemotherapy. ( Coates, A; Fox, RM; Friedlander, ML; Hedley, D; Kearsley, JH; Raghavan, D; Sims, K; Tattersall, MH, 1983)
"Nausea and vomiting are extremely common and most distressing side effects of high-dose cisplatin therapy."2.68Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial. ( Ata, E; Butt, A; Khan, MA; Khan, WA; Malik, IA; Qazilbash, M, 1995)
" It is concluded that oral lorazepam is an effective and safe adjuvant to MCP for the control of vomiting during cancer chemotherapy."2.67Low dose, oral lorazepam: a safe and effective adjuvant to antiemetic therapy. ( Advani, SH; Banavali, SD; Charak, BS; Gopal, R; Iyer, RS; Saikia, TK, 1991)
"56 female patients with breast carcinoma and treated with polychemotherapy: adriamycin, vindesine, ciclophosphamide and 5-fluorouracil were studied, divided in three groups with different antiemetic schedule: group A 40 mg/iv of metoclopramide; group B 40 mg iv of metoclopramide and 125 mg/iv of methylprednisolone before beginning chemotherapy; and group C 2 mg/oral of lorazepam, 125 mg/iv methyl-prednisolone and 1 mg/kg/oral of metoclopramide previously to begin chemotherapy; at two and four hours of the first dose, metoclopramide was repeated the same doses (really) three doses each two hours."2.67[Antiemetic treatments associated with antineoplastic chemotherapy]. ( Guillén Lloveria, G; Mayordomo Cámara, JJ; Sáenz Cusi, A; Sáez Martínez, MJ; Tres Sánchez, A, 1990)
"Severe nausea was significantly less frequent with cinnarizine and 59% of the chemotherapy days were without nausea, compared to 46% of the days without cinnarizine (p less than 0."2.67Cinnarizine for prevention of nausea and vomiting during platin chemotherapy. ( Osterwalder, B; Schimke, J; Senn, HJ; Wilder-Smith, CH, 1991)
"Four consecutive trials were undertaken to study lorazepam at each of three dosage levels and diphenhydramine when used in combination with iv metoclopramide and dexamethasone in patients receiving cisplatin at 120 mg/m2."2.66Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone. ( Clark, RA; Fiore, JJ; Gralla, RJ; Groshen, S; Kelsen, DP; Kris, MG; Tyson, LB, 1985)
" Ironically, chronic use of cannabis can result in paradoxical effects, including a condition known as cannabinoid hyperemesis syndrome."2.61Cannabinoid hyperemesis syndrome: An unrecognized cause of nausea and vomiting. ( Forest, CP; Smith, TN; Walsh, A, 2019)
"Vomiting was observed in 47/71 patients (66%) and 79/164 cycles (48%)."1.51Impact of adjuvant lorazepam with granisetron on chemotherapy-induced nausea and vomiting in pediatric patients with acute lymphoblastic leukemia. ( Goldman, RD; Hasegawa, D; Kishimoto, K; Kosaka, Y; Ono, A, 2019)
" The acute kidney injury was treated by administration of intravenous fluid."1.48[A Lot of Hot Steam: the Cannabinoid Hyperemesis Syndrome]. ( Gericke, M; Hartmann, D, 2018)
" A reduction in the dosage of benzodiazepines in the setting of epileptic patients with predominant autonomic symptoms may need to be considered."1.37Benzodiazepines in the acute management of seizures with autonomic manifestations: anticipate complications! ( Fluss, J; Gervaix, A; Korff, CM; Lacroix, L, 2011)
" Adverse events occurred in 4."1.34Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy. ( Cartwright, J; Frangoul, H; Ho, RH; Jones, E; Koyama, T; Kuttesch, J; Shankar, S; Whitlock, JA, 2007)
" Seventy-seven adverse events occurred in 68 (6."1.32Preprocedural fasting state and adverse events in children undergoing procedural sedation and analgesia in a pediatric emergency department. ( Agrawal, D; Gupta, R; Krauss, B; Manzi, SF, 2003)
" infusion via an ambulatory infusion pump with patient-activated intermittent dosing (BAD pump) for prevention of acute and delayed nausea/vomiting in patients receiving high-dose chemotherapy (HDC) for peripheral blood progenitor cell (PBPC) mobilization (MOB) or prior to autologous PBPC rescue."1.30Safety and efficacy of a continuous infusion, patient controlled anti-emetic pump to facilitate outpatient administration of high-dose chemotherapy. ( Belt, R; Coon, J; Cord, M; Dix, S; Geller, R; Howard, S, 1999)
"Despite treatment, emesis remains a major problem with cisplatin chemotherapy."1.28[Improved control of cisplatin-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam]. ( Hsu, KP; Li, YT; Mau, YK; Tsui, MS; Tu, FC, 1991)
"Nine advanced gastric cancer patients were given 17 courses of cisplatin administrations by means of a 24-hour intravenous infusion at a dose of 100 mg/m2."1.28[Treatment of nausea and vomiting induced by a 24-hour i.v. infusion of cisplatin]. ( Aoki, Y; Horiuchi, Y; Kamikawa, R; Kyokane, K; Miwa, Y; Nagai, H; Ninomiya, E; Noro, T; Suga, S; Yasue, K, 1990)
"Vomiting was totally abolished in 70% of patients; in only 4% two vomiting episodes occurred."1.27Improved tolerance of cytotoxic chemotherapy with lorazepam. A pilot study. ( Mughal, TI, 1983)

Research

Studies (93)

TimeframeStudies, this research(%)All Research%
pre-199032 (34.41)18.7374
1990's41 (44.09)18.2507
2000's10 (10.75)29.6817
2010's8 (8.60)24.3611
2020's2 (2.15)2.80

Authors

AuthorsStudies
Brown, JM1
Wilsey, MJ1
Dhana, L1
Lonsdale, H1
Cheung, F1
Doherty, SM1
Tatara, AW1
Ono, A1
Kishimoto, K1
Hasegawa, D1
Goldman, RD1
Kosaka, Y1
Gericke, M1
Hartmann, D1
Smith, TN1
Walsh, A1
Forest, CP1
Fletcher, DS1
Coyne, PJ1
Dodson, PW1
Parker, GG1
Wan, W1
Smith, TJ1
Murray-Brown, F1
Dorman, S1
Waqar, SN1
Mann, J1
Baggstrom, MQ1
Waqar, MA1
Chitneni, P1
Williams, K1
Gao, F1
Morgensztern, D1
Govindan, R1
Marchione, P1
Vento, C1
Marianetti, M1
Romeo, T1
Amabile, GA1
Giacomini, P1
Szwak, K1
Sacchetti, A1
Lacroix, L1
Fluss, J1
Gervaix, A1
Korff, CM1
Cooper, R1
Gent, P1
Agrawal, D1
Manzi, SF1
Gupta, R1
Krauss, B1
Jones, E1
Koyama, T1
Ho, RH1
Kuttesch, J1
Shankar, S1
Whitlock, JA1
Cartwright, J1
Frangoul, H1
Weschules, DJ1
Zimbroff, DL1
Marcus, RN1
Manos, G1
Stock, E1
McQuade, RD1
Auby, P1
Oren, DA1
DiFazio, MP1
Braun, L1
Freedman, S1
Hickey, P1
Bleicher, J1
Bhaskara, A1
Huyck, T1
Constantino, S1
Bardia, A1
Loprinzi, CL1
Silberstein, PT1
Maher, J1
Mundeleer, P1
Friedlander, M1
Kearsley, JH4
Tattersall, MH2
Friedlander, ML2
Sims, K2
Coates, A1
Hedley, D1
Raghavan, D1
Fox, RM1
Bishop, JF4
Olver, IN2
Wolf, MM2
Matthews, JP4
Long, M1
Bingham, J1
Hillcoat, BL2
Cooper, IA2
Gagen, M1
Gochnour, D1
Young, D1
Gaginella, T1
Neidhart, J1
Bowcock, SJ1
Stockdale, AD1
Bolton, JA1
Kang, AA1
Retsas, S1
Greenspoon, J1
Leuchter, RS2
Semrad, N1
Semrad, NF1
Townsend, DE1
Wade, ME1
Lagasse, LD1
Warde, P1
Cantwell, B1
Fennelly, J1
Powderly, W1
Conroy, R1
Mughal, TI2
Prentice, HG1
Cunningham, S1
Gandhi, L1
Cunningham, J1
Collis, C1
Hamon, MD1
McDermott, M1
Malik, IA1
Khan, WA1
Qazilbash, M1
Ata, E1
Butt, A1
Khan, MA1
Smith, RA1
Bleiberg, H1
Autier, P1
Michaux, D1
Misra, R1
Agarwal, N1
Buzdar, AU1
Esparza, L1
Natale, R1
Cody, R1
Calzone, K1
Benson, AB1
Sheehan, T1
Berry, W1
Fanning, J1
Hilgers, RD1
Ahn, MJ1
Lee, JS1
Lee, KH1
Suh, C1
Choi, SS1
Kim, SH1
Relling, MV1
Mulhern, RK1
Fairclough, D1
Baker, D1
Pui, CH1
Baltzer, L1
Kris, MG3
Tyson, LB3
Rigas, JR1
Pisters, KM1
Clerico, M1
Bertetto, O1
Morandini, MP1
Cardinali, C1
Giaccone, G1
Homesley, HD1
Hahne, WF1
McLees, B1
Heck, K1
Barrett, RJ1
Lentz, SS1
Woodlief, L1
Lovelace, JV1
Gilbert, CJ1
Ohly, KV1
Rosner, G1
Peters, WP1
Laraki, M1
el Mouknia, M1
Bouaguad, A1
Idali, B1
Benaguida, M1
Suga, S2
Iwase, H1
Shimada, M1
Nishio, Y1
Ichihara, T1
Ichihara, S1
Kusugami, K1
Saito, H1
Climent, MA1
Palau, J1
Ruiz, A1
Soriano, V1
Aznar, E1
Olmos, T1
Guillem, V1
Dix, S1
Cord, M1
Howard, S1
Coon, J1
Belt, R1
Geller, R1
Harousseau, JL1
Zittoun, R1
Bonneterre, J1
Hedouin, M1
Ouvry, J1
Manusirivithaya, S1
Chareoniam, V1
Isariyodom, P1
Sungsab, D1
Gale, G1
Galloon, S1
Fürst, CJ2
Johansson, S2
Fredrikson, M2
Hursti, T2
Steineck, G2
Peterson, C2
Dogliotti, L1
Antonacci, RA1
Pazè, E1
Ortega, C1
Berruti, A1
Faggiuolo, R1
Khalil, SN1
Berry, JM1
Howard, G1
Lawson, K1
Hanis, C1
Mazow, ML1
Stanley, TH1
Sands, R1
Roberts, JT1
Marsh, M1
Gill, A1
Oliver, IN1
Reynolds, S1
Walpole, E1
Rischin, D1
Buchanan, L1
Tan, LG1
Louvet, C1
Lorange, A1
Letendre, F1
Beaulieu, R1
Pretty, HM1
Courchesne, Y1
Neemeh, JA1
Monte, M1
Latreille, J1
Moreno, I1
Rosell, R1
Abad-Esteve, A1
Barnadas, A1
Carles, J1
Ribelles, N1
Mau, YK1
Li, YT1
Tsui, MS1
Tu, FC1
Hsu, KP1
González Barón, M1
Chacón, JI1
García Girón, C1
Ordóñez Gallego, A1
García de Paredes, ML1
Feliu, J1
Zamora, P1
Herranz, C1
Garrido, P1
Artal, A1
Charak, BS1
Banavali, SD1
Iyer, RS1
Saikia, TK1
Gopal, R1
Advani, SH1
Francom, M1
Wilder-Smith, CH2
Schimke, J1
Osterwalder, B1
Senn, HJ2
Molino, A1
Guglielmo, L1
Azzolini, ME1
Biondani, P1
Capelli, MC1
Grandinetti, A1
Griso, C1
Martinelli, G1
Martini, N1
Zanotti, R1
Herrstedt, J1
Hannibal, J1
Hallas, J1
Andersen, E1
Laursen, LC1
Hansen, M1
Campora, E1
Baldini, E1
Rubagotti, A1
Chiara, S1
Bruzzi, P1
Sertoli, MR1
Rosso, R1
Tres Sánchez, A1
Sáez Martínez, MJ1
Mayordomo Cámara, JJ1
Guillén Lloveria, G1
Sáenz Cusi, A1
Nagai, H1
Horiuchi, Y1
Kyokane, K1
Miwa, Y1
Aoki, Y1
Yasue, K1
Noro, T1
Kamikawa, R1
Ninomiya, E1
Stephens, SH1
Silvey, VL1
Wheeler, RH1
Ghosn, M1
Ha, MC1
Pietri, F1
Garcin, C1
Théodore, C1
Droz, JP1
Roila, F1
Basurto, C1
Bracarda, S1
Picciafuoco, M1
Ballatori, E1
Del Favero, A1
Tonato, M1
Hoffman, GS1
Leavitt, RY1
Fleisher, TA1
Minor, JR1
Fauci, AS1
Lucot, JB1
Crampton, GH1
Marshall, G1
Kerr, S1
Vowels, M1
O'Gorman-Hughes, D1
White, L1
O'Brien, ME1
Cullen, MH1
Woodroffe, C1
Kelly, K1
Burman, C1
Palmer, K1
Stuart, NS1
Blackledge, GR1
Sharpe, J1
Backonja, M1
Beinlich, B1
Dulli, D1
Schutta, HS1
Williams, AM1
Fiumara, AM1
Gordon, CJ1
Pazdur, R1
Ziccarelli, A1
Cummings, G1
Al-Sarraf, M1
Palmer, MC1
Colls, BM1
Gralla, RJ2
Clark, RA3
Groshen, S2
Wolf, M1
Scott, K1
Ackland, S1
Yuen, K1
Morton, C1
van Hoff, J1
Olszewski, D1
de Wit, R1
Veenhof, CH1
Craig, JB1
Powell, BL1
White, DR1
Capizzi, RL1
Briceland, LL1
Kodama, N1
Furuse, K1
Kawahara, M1
Arai, R1
Tsuruta, S1
Hayashi, S1
Kiyota, T1
Chan, MK1
Fiore, JJ1
Kelsen, DP1
Laszlo, J1
Hanson, DC1
Tyson, L1
Crumpler, L1
Gralla, R1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Do Patients Need Pre-Procedural Fasting for Coronary Artery Procedures?[NCT02562638]240 participants (Anticipated)Interventional2015-10-31Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

6 reviews available for lorazepam and Emesis

ArticleYear
Ketamine in Refractory Cyclic Vomiting Syndrome: A Case Report and Review of Literature.
    Journal of pharmacy practice, 2022, Volume: 35, Issue:5

    Topics: Adult; Analgesics; Anesthetics; Humans; Hypnotics and Sedatives; Ketamine; Lorazepam; Male; Ondanset

2022
Cannabinoid hyperemesis syndrome: An unrecognized cause of nausea and vomiting.
    JAAPA : official journal of the American Academy of Physician Assistants, 2019, Volume: 32, Issue:4

    Topics: Acute Disease; Antiemetics; Cannabinoids; Haloperidol; Humans; Lorazepam; Nausea; Syndrome; Vomiting

2019
Haloperidol for the treatment of nausea and vomiting in palliative care patients.
    The Cochrane database of systematic reviews, 2015, Nov-02, Issue:11

    Topics: Antiemetics; Diphenhydramine; Gels; Haloperidol; Humans; Lorazepam; Nausea; Palliative Care; Randomi

2015
An overview of chemotherapy-induced emesis highlighting the role of lorazepam as adjuvant therapy.
    International journal of palliative nursing, 2002, Volume: 8, Issue:7

    Topics: Antiemetics; Antineoplastic Agents; Chemotherapy, Adjuvant; Humans; Lorazepam; Quality of Life; Rand

2002
Cost-effectiveness analysis of antiemetic treatment.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1994, Volume: 2, Issue:3

    Topics: Antiemetics; Cost-Benefit Analysis; Costs and Cost Analysis; Dexamethasone; Europe; European Union;

1994
[The treatment of vomiting caused by the administration of cytostatic agents].
    Nederlands tijdschrift voor geneeskunde, 1986, Aug-16, Volume: 130, Issue:33

    Topics: Adrenal Cortex Hormones; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Humans; Loraz

1986

Trials

48 trials available for lorazepam and Emesis

ArticleYear
A randomized trial of the effectiveness of topical "ABH Gel" (Ativan(®), Benadryl(®), Haldol(®)) vs. placebo in cancer patients with nausea.
    Journal of pain and symptom management, 2014, Volume: 48, Issue:5

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antiemetics; Cross-Over Studies; Diphenhydramine;

2014
Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole.
    Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2

    Topics: Acute Disease; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dis

2007
Impairment of recall improves tolerance of cytotoxic chemotherapy.
    Lancet (London, England), 1983, Sep-17, Volume: 2, Issue:8351

    Topics: Anti-Anxiety Agents; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Drug Tole

1983
Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials

1984
A randomized trial of metoclopramide and a combination of dexamethasone and lorazepam for prevention of chemotherapy-induced vomiting.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; D

1984
Antiemetic prophylaxis with high dose metoclopramide or lorazepam in vomiting induced by chemotherapy.
    British medical journal (Clinical research ed.), 1984, Jun-23, Volume: 288, Issue:6434

    Topics: Cisplatin; Dacarbazine; Female; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Vomiting

1984
Granisetron in the prevention of irradiation-induced emesis.
    Bone marrow transplantation, 1995, Volume: 15, Issue:3

    Topics: Adult; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gra

1995
Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial.
    American journal of clinical oncology, 1995, Volume: 18, Issue:2

    Topics: Adult; Cisplatin; Clemastine; Dexamethasone; Drug Therapy, Combination; Female; Humans; Lorazepam; M

1995
Efficacy of Ondansetron and Lorazepam in controlling emesis associated with cytotoxic chemotherapy.
    Acta oncologica (Stockholm, Sweden), 1994, Volume: 33, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Humans; Lorazepam

1994
The roles of patient and observer assessments in anti-emetic trials.
    European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:9

    Topics: Cross-Over Studies; Double-Blind Method; Humans; Lorazepam; Metoclopramide; Nurses; Observer Variati

1994
Lorazepam-enhancement of the antiemetic efficacy of dexamethasone and promethazine. A placebo-controlled study.
    American journal of clinical oncology, 1994, Volume: 17, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Double-Blind Method; Dru

1994
Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy.
    Obstetrics and gynecology, 1994, Volume: 83, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Dexamethasone; Diphenh

1994
A randomized double-blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and lorazepam in the prevention of emesis due to cisplatin-based chemotherapy.
    American journal of clinical oncology, 1994, Volume: 17, Issue:2

    Topics: Adult; Aged; Cisplatin; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Human

1994
Chlorpromazine with and without lorazepam as antiemetic therapy in children receiving uniform chemotherapy.
    The Journal of pediatrics, 1993, Volume: 123, Issue:5

    Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Ch

1993
The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatin.
    Cancer, 1994, Feb-01, Volume: 73, Issue:3

    Topics: Adult; Aged; Cisplatin; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Fema

1994
Antiemetic activity of oral lorazepam in addition to methylprednisolone and metoclopramide in the prophylactic treatment of vomiting induced by cisplatin. A double-blind, placebo-controlled study with crossover design.
    Tumori, 1993, Apr-30, Volume: 79, Issue:2

    Topics: Adult; Aged; Cisplatin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lorazepam; M

1993
Randomized comparison of the antiemetic efficacy of a serotonin type 3 receptor antagonist (MDL 72,222) with a high-dose metoclopramide regimen.
    American journal of clinical oncology, 1993, Volume: 16, Issue:2

    Topics: Adult; Aged; Antiemetics; Cisplatin; Diphenhydramine; Drug Therapy, Combination; Female; Genital Neo

1993
Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation.
    Cancer, 1995, Dec-01, Volume: 76, Issue:11

    Topics: Adult; Antiemetics; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combine

1995
[Prevention of postoperative nausea and vomiting by lorazepam].
    Cahiers d'anesthesiologie, 1996, Volume: 44, Issue:2

    Topics: Adult; Anti-Anxiety Agents; Humans; Lorazepam; Nausea; Placebos; Postoperative Complications; Preane

1996
Neoadjuvant chemotherapy in scirrhous cancer of the stomach using uracil and tegafur and cisplatin.
    Internal medicine (Tokyo, Japan), 1996, Volume: 35, Issue:12

    Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy

1996
[Improvement in the control of chemotherapy induced emesis with ondansetron, methylprednisolone and lorazepam combination in patients treated by a moderate emetic treatment and uncontrolled by a previous antiemetic combination].
    Bulletin du cancer, 2000, Volume: 87, Issue:6

    Topics: Adult; Antiemetics; Breast Neoplasms; Double-Blind Method; Drug Therapy, Combination; Female; Hemato

2000
Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2001, Volume: 84, Issue:7

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Chi-Square Distribution; Cisplatin; Dexamethasone;

2001
Lorazepam as a premedication.
    Canadian Anaesthetists' Society journal, 1976, Volume: 23, Issue:1

    Topics: Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Female; Humans; Lorazepam; Male; Memory; Nause

1976
Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients.
    Drugs, 1992, Volume: 43 Suppl 3

    Topics: Adult; Aged; Antiemetics; Cisplatin; Female; Humans; Indoles; Lorazepam; Male; Metoclopramide; Middl

1992
The antiemetic effect of lorazepam after outpatient strabismus surgery in children.
    Anesthesiology, 1992, Volume: 77, Issue:5

    Topics: Adolescent; Ambulatory Surgical Procedures; Antiemetics; Child; Child, Preschool; Double-Blind Metho

1992
A randomised trial of dexamethasone, lorazepam and prochlorperazine for emesis in patients receiving chemotherapy.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28, Issue:1

    Topics: Adult; Aged; Antiemetics; Cisplatin; Dexamethasone; Double-Blind Method; Drug Therapy, Combination;

1992
Randomized trial for the control of acute vomiting in cisplatin-treated patients: high-dose metoclopramide with dexamethasone and lorazepam as adjuncts versus high-dose alizapride plus dexamethasone and lorazepam. Study of the incidence of delayed emesis.
    Oncology, 1991, Volume: 48, Issue:5

    Topics: Antiemetics; Cisplatin; Dexamethasone; Humans; Lorazepam; Metoclopramide; Nausea; Prospective Studie

1991
Effects of ondansetron on chemotherapy-induced acute and delayed emesis--a pilot study.
    Acta oncologica (Stockholm, Sweden), 1991, Volume: 30, Issue:5

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Biperiden; Cisplatin; Dexa

1991
Antiemetic regimens in outpatients receiving cisplatin and non-cisplatin chemotherapy. A randomized trial comparing high-dose metoclopramide plus methylprednisolone with and without lorazepam.
    Acta oncologica (Stockholm, Sweden), 1991, Volume: 30, Issue:5

    Topics: Antineoplastic Agents; Cisplatin; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Methyl

1991
Low dose, oral lorazepam: a safe and effective adjuvant to antiemetic therapy.
    Indian journal of cancer, 1991, Volume: 28, Issue:2

    Topics: Adjuvants, Pharmaceutic; Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemothera

1991
Cinnarizine for prevention of nausea and vomiting during platin chemotherapy.
    Acta oncologica (Stockholm, Sweden), 1991, Volume: 30, Issue:6

    Topics: Adult; Aged; Carboplatin; Cinnarizine; Cisplatin; Combined Modality Therapy; Female; Humans; Lorazep

1991
The antiemetic activity of high-dose metoclopramide and high-dose alizapride in combination with lorazepam in patients receiving cancer chemotherapy. A prospective, randomized, double-blind study.
    Oncology, 1991, Volume: 48, Issue:2

    Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Double-Blind Method; Drug Therapy, Comb

1991
High-dose metoclopramide + lorazepam versus low-dose metoclopramide + lorazepam + dehydrobenzperidol in the treatment of cisplatin-induced nausea and vomiting.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2, Issue:3

    Topics: Adult; Aged; Cisplatin; Double-Blind Method; Droperidol; Drug Therapy, Combination; Female; Humans;

1991
Double-blind randomized trial of lorazepam versus placebo with methylprednisolone for control of emesis due to non-cisplatin containing chemotherapy.
    Journal of chemotherapy (Florence, Italy), 1990, Volume: 2, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Double-Blind Method;

1990
[Antiemetic treatments associated with antineoplastic chemotherapy].
    Anales de medicina interna (Madrid, Spain : 1984), 1990, Volume: 7, Issue:5

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dox

1990
A randomized, double-blind comparison of the antiemetic effect of metoclopramide and lorazepam with or without dexamethasone in patients receiving high-dose cisplatin.
    Cancer, 1990, Aug-01, Volume: 66, Issue:3

    Topics: Adult; Aged; Cisplatin; Dexamethasone; Double-Blind Method; Drug Evaluation; Female; Humans; Lorazep

1990
[Trial of premedication with lorazepam for the prevention of emetic effects of cisplatin].
    Bulletin du cancer, 1990, Volume: 77, Issue:7

    Topics: Cisplatin; Double-Blind Method; Humans; Lorazepam; Premedication; Vomiting

1990
Antiemetic therapy for chemotherapy-induced vomiting: metoclopramide, benztropine, dexamethasone, and lorazepam regimen compared with chlorpromazine alone.
    The Journal of pediatrics, 1989, Volume: 115, Issue:1

    Topics: Adolescent; Antineoplastic Agents; Benztropine; Child; Child, Preschool; Chlorpromazine; Clinical Tr

1989
The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial.
    British journal of cancer, 1989, Volume: 60, Issue:5

    Topics: Adult; Aged; Cisplatin; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Human

1989
Antiemetic superiority of lorazepam over oxazepam and methylprednisolone as premedicants for patients receiving cisplatin-containing chemotherapy.
    Cancer, 1989, Oct-15, Volume: 64, Issue:8

    Topics: Adolescent; Adult; Aged; Antiemetics; Cisplatin; Female; Humans; Lorazepam; Male; Methylprednisolone

1989
Metoclopramide versus metoclopramide and lorazepam. Superiority of combined therapy in the control of cisplatin-induced emesis.
    Cancer, 1989, Feb-01, Volume: 63, Issue:3

    Topics: Adult; Aged; Amnesia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Lor

1989
Amelioration of cytotoxic-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam.
    Cancer chemotherapy and pharmacology, 1987, Volume: 19, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Dexamethasone;

1987
Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial.
    Cancer, 1987, Dec-01, Volume: 60, Issue:11

    Topics: Adult; Aged; Cisplatin; Clinical Trials as Topic; Dexamethasone; Diphenhydramine; Double-Blind Metho

1987
Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapy.
    Cancer treatment reports, 1987, Volume: 71, Issue:11

    Topics: Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Com

1987
[The treatment of vomiting caused by the administration of cytostatic agents].
    Nederlands tijdschrift voor geneeskunde, 1986, Aug-16, Volume: 130, Issue:33

    Topics: Adrenal Cortex Hormones; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Humans; Loraz

1986
Antiemetic therapy in patients treated with high-dose cytosine arabinoside.
    Oncology, 1987, Volume: 44, Issue:2

    Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Clinical Trials as Topic; Cytarabine; Drug Therapy,

1987
[Anti-emetic treatment with metoclopramide and other drugs during CDDP therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:1

    Topics: Aged; Cisplatin; Dexamethasone; Female; Humans; Lorazepam; Lung Neoplasms; Male; Metoclopramide; Mid

1987
Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone.
    Cancer treatment reports, 1985, Volume: 69, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Cisplatin; Clinical Trials as

1985

Other Studies

40 other studies available for lorazepam and Emesis

ArticleYear
Acute Treatment of Adolescent Cannabinoid Hyperemesis Syndrome With Haloperidol, Lorazepam, and/or Capsaicin: A Single Institution Case Series.
    Journal of psychiatric practice, 2023, 09-01, Volume: 29, Issue:5

    Topics: Adolescent; Adult; Cannabinoids; Capsaicin; Child; Haloperidol; Humans; Lorazepam; Nausea; Syndrome;

2023
Impact of adjuvant lorazepam with granisetron on chemotherapy-induced nausea and vomiting in pediatric patients with acute lymphoblastic leukemia.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2019, Volume: 27, Issue:3

    Topics: Adjuvants, Pharmaceutic; Adolescent; Adrenal Cortex Hormones; Anthracyclines; Antiemetics; Antineopl

2019
[A Lot of Hot Steam: the Cannabinoid Hyperemesis Syndrome].
    Deutsche medizinische Wochenschrift (1946), 2018, Volume: 143, Issue:16

    Topics: Abdominal Pain; Acute Kidney Injury; Adult; Combined Modality Therapy; Fluid Therapy; Humans; Loraze

2018
Delayed nausea and vomiting from carboplatin doublet chemotherapy.
    Acta oncologica (Stockholm, Sweden), 2016, Volume: 55, Issue:6

    Topics: Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Lora

2016
Hemiballismus in subthalamic haemorrhage: efficacy of levetiracetam.
    European journal of neurology, 2009, Volume: 16, Issue:6

    Topics: Aged; Anti-Dyskinesia Agents; Anticonvulsants; Antihypertensive Agents; Ataxia; Cerebellum; Dose-Res

2009
Droperidol use in pediatric emergency department patients.
    Pediatric emergency care, 2010, Volume: 26, Issue:4

    Topics: Adjuvants, Anesthesia; Adolescent; Anti-Anxiety Agents; Antiemetics; Central Nervous System Depressa

2010
Benzodiazepines in the acute management of seizures with autonomic manifestations: anticipate complications!
    Epilepsia, 2011, Volume: 52, Issue:10

    Topics: Autonomic Nervous System Diseases; Benzodiazepines; Child; Child, Preschool; Diazepam; Female; Human

2011
Preprocedural fasting state and adverse events in children undergoing procedural sedation and analgesia in a pediatric emergency department.
    Annals of emergency medicine, 2003, Volume: 42, Issue:5

    Topics: Adjuvants, Anesthesia; Analgesia; Anesthetics, Combined; Child; Child, Preschool; Chloral Hydrate; C

2003
Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy.
    Pediatric blood & cancer, 2007, Volume: 48, Issue:3

    Topics: Adolescent; Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Confusion; Dexamethasone; D

2007
Tolerability of the compound ABHR in hospice patients.
    Journal of palliative medicine, 2005, Volume: 8, Issue:6

    Topics: Aged; Antiemetics; Cohort Studies; Diphenhydramine; Drug Combinations; Female; Haloperidol; Hospice

2005
Rotavirus-induced seizures in childhood.
    Journal of child neurology, 2007, Volume: 22, Issue:12

    Topics: Anticonvulsants; Child, Preschool; Diarrhea; Enterovirus; Feces; Female; Follow-Up Studies; Humans;

2007
Lorazepam, diphenhydramine, and haloperidol transdermal gel for rescue from chemotherapy-induced nausea/vomiting: results of two pilot trials.
    The journal of supportive oncology, 2008, Volume: 6, Issue:1

    Topics: Administration, Cutaneous; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Clini

2008
Intravenous lorazepam to prevent nausea and vomiting associated with cancer chemotherapy.
    Lancet (London, England), 1981, Jan-10, Volume: 1, Issue:8211

    Topics: Anti-Anxiety Agents; Antineoplastic Agents; Humans; Injections, Intravenous; Lorazepam; Nausea; Neop

1981
Child premedication per os with lorazepam.
    Acta anaesthesiologica Belgica, 1980, Volume: 31 Suppl

    Topics: Administration, Oral; Anesthesia, General; Anti-Anxiety Agents; Anxiety; Child; Child, Preschool; Do

1980
Oral lorazepam to improve tolerance of cytotoxic therapy.
    Lancet (London, England), 1981, Jun-13, Volume: 1, Issue:8233

    Topics: Administration, Oral; Anti-Anxiety Agents; Antineoplastic Agents; Humans; Lorazepam; Vomiting

1981
Lorazepam as an adjunct to antiemetic therapy with haloperidol in patients receiving cytotoxic chemotherapy.
    Australian and New Zealand journal of medicine, 1983, Volume: 13, Issue:1

    Topics: Anti-Anxiety Agents; Antiemetics; Antineoplastic Agents; Drug Therapy, Combination; Female; Haloperi

1983
Lorazepam for chemotherapy-induced emesis.
    Archives of internal medicine, 1984, Volume: 144, Issue:12

    Topics: Humans; Lorazepam; Vomiting

1984
A pilot study of lorazepam-induced amnesia with cis-platinum-containing chemotherapy.
    Gynecologic oncology, 1984, Volume: 17, Issue:3

    Topics: Adult; Aged; Cisplatin; Female; Humans; Lorazepam; Memory; Middle Aged; Ovarian Neoplasms; Pilot Pro

1984
Alleviation of chemotherapy induced emesis by oral lorazepam and domperidone.
    Irish journal of medical science, 1983, Volume: 152, Issue:9

    Topics: Adult; Antineoplastic Agents; Domperidone; Drug Therapy, Combination; Female; Humans; Lorazepam; Mal

1983
Improved tolerance of cytotoxic chemotherapy with lorazepam. A pilot study.
    Oncology, 1983, Volume: 40, Issue:6

    Topics: Adult; Antiemetics; Antineoplastic Agents; Drug Evaluation; Humans; Lorazepam; Lymphoma; Middle Aged

1983
DAB: a three-drug combination provides alternative to 5-HT3 receptor drugs.
    Oncology nursing forum, 1995, Volume: 22, Issue:4

    Topics: Antineoplastic Agents; Dexamethasone; Diphenhydramine; Drug Combinations; Humans; Lorazepam; Nausea;

1995
Effective control of cisplatin induced emesis by combination drug regimen.
    Indian journal of cancer, 1994, Volume: 31, Issue:1

    Topics: Adult; Cisplatin; Dexamethasone; Drug Administration Schedule; Drug Combinations; Female; Follow-Up

1994
The antiemetic efficacy of granisetron plus dexamethasone, haloperidol and loracepam in breast cancer patients treated with high-dose chemotherapy with peripheral blood stem-cell support.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1998, Volume: 6, Issue:3

    Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dexamethasone;

1998
Safety and efficacy of a continuous infusion, patient controlled anti-emetic pump to facilitate outpatient administration of high-dose chemotherapy.
    Bone marrow transplantation, 1999, Volume: 24, Issue:5

    Topics: Adult; Ambulatory Care; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasm

1999
Control of cisplatin induced emesis--a multidisciplinary intervention strategy.
    Medical oncology and tumor pharmacotherapy, 1992, Volume: 9, Issue:2

    Topics: Adult; Aged; Biperiden; Cisplatin; Female; Humans; Lorazepam; Metoclopramide; Middle Aged; Nausea; O

1992
Low dose ondansetron and dexamethasone: a cost effective alternative to high dose metoclopramide/dexamethasone/lorazepam in the prevention of acute cisplatin induced emesis.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1992, Volume: 4, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Cisplatin; Cost-Benefit Analysis; Dexamethasone; Female

1992
Acute and delayed emesis after cisplatin-based regimen: description and prevention.
    Oncology, 1991, Volume: 48, Issue:5

    Topics: Acute Disease; Antiemetics; Cisplatin; Dexamethasone; Dose-Response Relationship, Drug; Humans; Lora

1991
[Improved control of cisplatin-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam].
    Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1991, Volume: 47, Issue:2

    Topics: Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Humans; Lorazepam; Metoclopramide; Vomi

1991
Compounding nausea aid.
    American pharmacy, 1991, Volume: NS31, Issue:7

    Topics: Benztropine; Chemistry, Pharmaceutical; Dexamethasone; Diphenhydramine; Drug Combinations; Drug Comp

1991
[Treatment of nausea and vomiting induced by a 24-hour i.v. infusion of cisplatin].
    Gan no rinsho. Japan journal of cancer clinics, 1990, Volume: 36, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Drug Therapy, Combination;

1990
A pilot study of metoclopramide, dexamethasone, diphenhydramine and lorazepam in prevention of nausea and vomiting in cisplatin-treated male patients.
    Oncology, 1990, Volume: 47, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Diphenhydramine; Drug Eval

1990
Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide.
    The American journal of medicine, 1990, Volume: 89, Issue:4

    Topics: Adult; Aged; Cyclophosphamide; Drug Administration Schedule; Female; Granulomatosis with Polyangiiti

1990
8-OH-DPAT suppresses vomiting in the cat elicited by motion, cisplatin or xylazine.
    Pharmacology, biochemistry, and behavior, 1989, Volume: 33, Issue:3

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Cats; Cisplatin; Dose-Response Relationship, Drug;

1989
Antiemetic prophylaxis of cancer chemotherapy-induced nausea and vomiting with cinnarizine and lorazepam.
    Oncology, 1989, Volume: 46, Issue:3

    Topics: Administration, Oral; Adult; Antiemetics; Antineoplastic Agents; Cinnarizine; Cisplatin; Drug Therap

1989
Haloperidol and lorazepam for the treatment of nausea and vomiting associated with the treatment of intractable migraine headaches.
    Archives of neurology, 1989, Volume: 46, Issue:7

    Topics: Adult; Dihydroergotamine; Female; Haloperidol; Humans; Lorazepam; Migraine Disorders; Nausea; Vomiti

1989
Lorazepam for the control of chemotherapy-related nausea and vomiting in children.
    The Journal of pediatrics, 1988, Volume: 113, Issue:1 Pt 1

    Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Humans; Lorazepam; Nausea; Pilot Project

1988
Lorazepam as an adjunct to antiemetic therapy in patients receiving cytotoxic chemotherapy.
    Connecticut medicine, 1987, Volume: 51, Issue:3

    Topics: Antiemetics; Antineoplastic Agents; Drug Therapy, Combination; Humans; Lorazepam; Nausea; Vomiting

1987
Corticosteroids and lorazepam as antiemetics in cancer chemotherapy.
    Drug and therapeutics bulletin, 1986, Jun-16, Volume: 24, Issue:12

    Topics: Adrenal Cortex Hormones; Antiemetics; Antineoplastic Agents; Drug Therapy, Combination; Humans; Lora

1986
Lorazepam as an antiemetic.
    Journal of the Association of Pediatric Oncology Nurses, 1985,Fall, Volume: 2, Issue:4

    Topics: Antiemetics; Antineoplastic Agents; Child; Humans; Lorazepam; Vomiting

1985
Lorazepam in cancer patients treated with cisplatin: a drug having antiemetic, amnesic, and anxiolytic effects.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:6

    Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Cisplatin; Female; Huma

1985